AntagOnize Plasminogen Activator Inhibitor-1

· Northwestern University

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AntagOnize Plasminogen Activator Inhibitor-1, covering 2025-03-03 to 2025-03-03. Get the full timeline:

Most recent: Clinical Trial Update: Study to AntagOnize Plasminogen Activator Inhibitor-1 in Severe COVID-19 [Phase 1, Phase 2]